Literature DB >> 24091606

Differences in disease expression between primary ciliary dyskinesia and cystic fibrosis with and without pancreatic insufficiency.

Malena Cohen-Cymberknoh1, Natalia Simanovsky2, Nurith Hiller2, Alex Gileles Hillel3, David Shoseyov1, Eitan Kerem4.   

Abstract

BACKGROUND: Impaired mucociliary clearance causes pulmonary disease in primary ciliary dyskinesia (PCD) and contributes to cystic fibrosis (CF) lung disease. Although the sinopulmonary disease is similar, morbidity and mortality are different. Both patients with PCD and patients with CF with pancreatic sufficiency (CF-PS) show no nutrient malabsorption and are diagnosed at a later age compared with patients with CF with pancreatic insufficiency (CF-PI).
METHODS: Clinical status, microbiology, FEV1, and high-resolution CT (HRCT) scans presented as total Brody score (CT-TBS) were compared for patients with PCD, CF-PI, and CF-PS, all treated at the same medical center, by the same team, and by a similar routine follow-up.
RESULTS: One hundred sixty-four patients, 34 with PCD, 88 with CF-PI, and 42 with CF-PS were enrolled. PCD was diagnosed at a similar age as CF-PS but significantly later than CF-PI. Mean FEV1 % predicted was similar for the three groups. The rate of FEV1 change with age in PCD was similar to CF-PS but significantly lower than in CF-PI. Severity of structural lung disease (CT-TBS) was similar for PCD and CF-PS and significantly higher in CF-PI. No correlation between TBS or Pseudomonas aeruginosa infection and FEV1 in PCD was seen, whereas a negative correlation with FEV1 was observed for both CF groups.
CONCLUSIONS: Although in our study PCD was similar to CF-PS, the lack of correlation between FEV1 and age, CT-TBS, and P aeruginosa infection in PCD suggests that impaired mucociliary clearance is not the only cause for inducing pulmonary damage in these diseases. Furthermore, a comparison of disease characteristics for PCD and CF should distinguish between CF-PI and CF-PS as different entities.

Entities:  

Mesh:

Year:  2014        PMID: 24091606     DOI: 10.1378/chest.13-1162

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  24 in total

1.  Extended Interval Tobramycin Pharmacokinetics in a Pediatric Patient With Primary Ciliary Dyskinesia Presenting With an Acute Respiratory Exacerbation.

Authors:  Kristi L Higgins; Cady Noda; Jeremy S Stultz
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Mar-Apr

Review 2.  Sleep disorders in cystic fibrosis: A systematic review and meta-analysis.

Authors:  Joel Reiter; Alex Gileles-Hillel; Malena Cohen-Cymberknoh; Dennis Rosen; Eitan Kerem; David Gozal; Erick Forno
Journal:  Sleep Med Rev       Date:  2020-02-19       Impact factor: 11.609

Review 3.  Origins of cystic fibrosis lung disease.

Authors:  David A Stoltz; David K Meyerholz; Michael J Welsh
Journal:  N Engl J Med       Date:  2015-01-22       Impact factor: 91.245

Review 4.  Sleep in children with cystic fibrosis: More under the covers.

Authors:  Joel Reiter; Oded Breuer; Malena Cohen-Cymberknoh; Erick Forno; Alex Gileles-Hillel
Journal:  Pediatr Pulmonol       Date:  2021-05-20

5.  Primary Ciliary Dyskinesia: Longitudinal Study of Lung Disease by Ultrastructure Defect and Genotype.

Authors:  Stephanie D Davis; Margaret Rosenfeld; Hye-Seung Lee; Thomas W Ferkol; Scott D Sagel; Sharon D Dell; Carlos Milla; Jessica E Pittman; Adam J Shapiro; Kelli M Sullivan; Keith R Nykamp; Jeffrey P Krischer; Maimoona A Zariwala; Michael R Knowles; Margaret W Leigh
Journal:  Am J Respir Crit Care Med       Date:  2019-01-15       Impact factor: 30.528

6.  Collecting clinical data in primary ciliary dyskinesia- challenges and opportunities.

Authors:  Israel Amirav; Mary Roduta Roberts; Huda Mussaffi; Avigdor Mandelberg; Yehudah Roth; Revital Abitbul; Anthony Luder; Hannah Blau; Soliman Alkrinawi; Micha Aviram; Marta Ben-Ami; Moshe Rotschild; Lea Bentur; David Shoseyov; Malena Cohen-Cymberknoh; Eitan Kerem; Avraham Avital; Chaim Springer; Avigdor Hevroni; Husein Dabbah; Arnon Elizur; Elie Picard; Shmuel Goldberg; Joseph Rivlin; Galit Livnat; Moran Lavie; Nael Alias; Ruth Soferman; Heike Olbrich; Johanna Raidt; Julia Wallmeier; Claudius Werner; Niki T Loges; Heymut Omran
Journal:  F1000Res       Date:  2016-08-18

7.  Impaired mucus detachment disrupts mucociliary transport in a piglet model of cystic fibrosis.

Authors:  Mark J Hoegger; Anthony J Fischer; James D McMenimen; Lynda S Ostedgaard; Alex J Tucker; Maged A Awadalla; Thomas O Moninger; Andrew S Michalski; Eric A Hoffman; Joseph Zabner; David A Stoltz; Michael J Welsh
Journal:  Science       Date:  2014-08-15       Impact factor: 47.728

Review 8.  Diagnosis and management of primary ciliary dyskinesia.

Authors:  Jane S Lucas; Andrea Burgess; Hannah M Mitchison; Eduardo Moya; Michael Williamson; Claire Hogg
Journal:  Arch Dis Child       Date:  2014-04-25       Impact factor: 3.791

9.  Study protocol, rationale and recruitment in a European multi-centre randomized controlled trial to determine the efficacy and safety of azithromycin maintenance therapy for 6 months in primary ciliary dyskinesia.

Authors:  Helene E Kobbernagel; Frederik F Buchvald; Eric G Haarman; Carmen Casaulta; Samuel A Collins; Claire Hogg; Claudia E Kuehni; Jane S Lucas; Heymut Omran; Alexandra L Quittner; Claudius Werner; Kim G Nielsen
Journal:  BMC Pulm Med       Date:  2016-07-22       Impact factor: 3.317

Review 10.  Diagnosis, monitoring, and treatment of primary ciliary dyskinesia: PCD foundation consensus recommendations based on state of the art review.

Authors:  Adam J Shapiro; Maimoona A Zariwala; Thomas Ferkol; Stephanie D Davis; Scott D Sagel; Sharon D Dell; Margaret Rosenfeld; Kenneth N Olivier; Carlos Milla; Sam J Daniel; Adam J Kimple; Michele Manion; Michael R Knowles; Margaret W Leigh
Journal:  Pediatr Pulmonol       Date:  2015-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.